We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Morgan Stanley Finance Auto-Callable Notes Due Nov 2029

Morgan Stanley Finance LLC filed a free writing prospectus on November 9, 2026, for Market Linked Securities (Preliminary Pricing Supplement No. 19,955) linked to the lowest performing of three equity indexes, with an expected maturity of November 23, 2029.

Nitish Kishor | 09 November 2026

Werewolf Therapeutics Releases WTX-124 and WTX-330 Clinical Data

Werewolf Therapeutics, Inc. filed a Form 8-K with the SEC on November 9, 2026, disclosing new clinical data from its Phase 1/1b trial of WTX-124 and its Phase 1b/2 trial of WTX-330 for the treatment of solid tumors.

Shwetambri Chauhan | 09 November 2026

Surgery Partners Amends Merger Terms, Price Lifted to $25.00

Surgery Partners, Inc. filed a current report on November 9, 2026, disclosing that on November 8, 2026, it entered into Amendment No. 1 to its Agreement and Plan of Merger with Spyglass Topco, LLC, Spyglass Merger Subsidiary, Inc., and guarantor Bon Secours Mercy Health, …

Aditi Sarkar | 09 November 2026

Langrock Forfeits 3,720 Shares in 1-800-Flowers Tax Withholding

James M. Langrock, Chief Financial Officer and SVP of 1 800 Flowers Com Inc, filed a Form 4 on November 9, 2026, disclosing a share withholding transaction on November 5, 2026, related to the vesting of restricted stock.

Aditi Sarkar | 09 November 2026

Illumina Launches Duplex ctDNA Sequencing Early Access Program

Illumina, Inc. issued a press release on November 9, 2026, announcing an early access program for a new ultrasensitive duplex sequencing workflow designed to detect circulating tumor DNA in plasma samples for molecular residual disease research.

Anjali Anand | 09 November 2026

Nkarta NKX019 Ntrust Trial Data: Myositis and Sclerosis

Nkarta, Inc. filed an 8-K on November 9, 2026, disclosing initial clinical data from its Phase 1/2 Ntrust-2 basket study and integrated safety data from its Ntrust-1 and Ntrust-2 trials evaluating NKX019 in myositis and systemic sclerosis, presented at ACR Convergence 2026.

Aakashdeep | 09 November 2026

Citigroup 6-Year SPX Buffer Securities, 81.75% Cap

Citigroup Global Markets Holdings Inc. filed a free writing prospectus on November 9, 2026, disclosing preliminary terms for 6-Year Buffer Securities linked to the S&P 500 Index, with a pricing date of November 23, 2026, and maturity on November 29, 2032.

Nitish Kishor | 09 November 2026

Surgery Partners Raises Merger Price to $25.00 Per Share

Surgery Partners, Inc. filed a current report on Form 8-K on November 9, 2026, disclosing that it entered into Amendment No. 1 to its Agreement and Plan of Merger on November 8, 2026, increasing the merger consideration and revising related terms of its previously …

Anjali Anand | 09 November 2026

TMC Metals Gets NOAA Mid-December Permit Timeline Letter

TMC The Metals Company Inc. filed a Form 8-K on November 9, 2026, disclosing that its subsidiary TMC USA received a letter from NOAA on November 3, 2026, stating that NOAA expects to notify TMC USA by mid-December 2026 of its final determination on …

Anjali Anand | 09 November 2026

Andy Waters Disposes 320 Shares of Community Trust Bancorp

Community Trust Bancorp Inc /KY/ Executive Vice President Andy D. Waters filed a Form 4 on November 9, 2026, disclosing a disposition of 320 shares of common stock on November 6, 2026.

Aakashdeep | 09 November 2026
Support

Hi! How can we help you today?

Loading…